Jamp-Quinine (2014-11-21)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Natural health products
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 100 caps Format: (L) 26293, (L) 27460 | B. Jamp-Quinine 300 mg | - Recalling Firm
- Jamp Pharma Inc.
- 1380-203 Newton Street
- Boucherville
- J4B 5H2
- Quebec
- CANADA
- Marketing Authorization Holder
- Jamp Pharma Inc.
- 1380-203 Newton Street
- Boucherville
- J4B 5H2
- Quebec
- CANADA
| Capsule | NPN 80040277 | 300 mg |
| 100 caps Format: | A. Jamp-Quinine 200 mg | - Recalling Firm
- Jamp Pharma Inc.
- 1380-203 Newton Street
- Boucherville
- J4B 5H2
- Quebec
- CANADA
- Marketing Authorization Holder
- Jamp Pharma Inc.
- 1380-203 Newton Street
- Boucherville
- J4B 5H2
- Quebec
- CANADA
| Capsule | NPN 80040279 | 200 mg |
Recalled Products
-
Jamp-Quinine 200 mg
-
Jamp-Quinine 300 mg
The product was recalled following the addition of quinine or its salts or derivatives to the Prescription Drug List.
Wholesalers and Retailers